858
Views
4
CrossRef citations to date
0
Altmetric
Letter

Mass psychogenic illness following HPV immunization in Carmen de Bolivar, Colombia (2014): more uncertainty is required

ORCID Icon, ORCID Icon & ORCID Icon
Pages 1199-1200 | Received 30 Dec 2018, Accepted 16 Jan 2019, Published online: 02 Apr 2019

ABSTRACT

The interesting article by Simas et. al. describes an outbreak case with over 600 individuals who exhibited neurological symptoms and which occurred in a town located at the northern region of Colombia in 2014. The community associated this event to the second-dose vaccination campaign against the Human Papillomavirus (HPV) and scientists defined it as a mass psychogenic illness. Unfortunately, the authors did not include in their article important findings related to a case-control study (with n = 137 and n = 437, respectively), conducted by the Colombian government. After inquiring “have you ever received vaccination against human papillomavirus?”, a significant association with the vaccine was identified (adjusted OR: 10.8, 95% CI: 1.4–80.2).

Dear editor:

The interesting article by Simas et al. describes an outbreak case with over 600 individuals who exhibited neurological symptoms and which occurred in a town located at the northern region of Colombia in 2014. The community associated this event to the second-dose vaccination campaign against the Human Papillomavirus (HPV) and scientists defined it as a mass psychogenic illness.Citation1,Citation2 Unfortunately, the authors did not include in their article important findings related to a case-control study (with n = 137 and n = 437, respectively), conducted by the Colombian government. After inquiring “have you ever received vaccination against human papillomavirus?”, a significant association with the vaccine was identified (adjusted OR: 10.8, 95% CI: 1.4-80.2). A similar situation occurred when questioning “how many doses of the vaccine have you had applied?”, which was answered with “just one dose” (as the reference category) and “more than one dose” (adjusted OR: 1.95, 95% CI: 1.02-3.74). Similar results were achieved throughout several questions which investigated about psychosocial factors, leading to the diagnosis of mass psychogenic illness. Data related to the vaccine and the bizarre signs and symptoms were available online at the Colombian National Institute of Health website, but they are no longer easily accessible through public records.

While the intention is not to argue against the case correspondence to a clear example of mass psychogenic illness, it is interesting that the possible role of vaccination was not comprehensively discussed when facts did indicate that it influenced the event. A possible hypothesis that comes from situations like these, is the current partial understanding of the adverse effects that vaccination against HPV could potentially display in a population with a specific set of sociocultural traits. From one point of view, the hegemonic approximation towards the analysis of adverse effects of medicines prioritizes chemical or pharmacological explanations,Citation3 putting aside all adverse effects that have psychosocial or sociocultural mechanisms of action. On the other hand, mass psychogenic illnesses are by definition group events, not individual, requiring an ecological or multilevel approach.Citation4 Therefore, mass psychogenic illnesses represent more than a group of individuals with conversion disorder,Citation5 and it is necessary to understand the social, cultural and maybe even economic determinants associated with their occurrence,Citation6 which do not necessarily correspond to risk factorsCitation7 for the aforementioned disease (see ).

Figure 1. Suggested multilevel approach for exploring conversion disorder and mass psychogenic illness related with vaccines.

Figure 1. Suggested multilevel approach for exploring conversion disorder and mass psychogenic illness related with vaccines.

In conclusion, given that vaccines against HPV are still under rigorous scientific research, and more accurate data regarding their effectiveness and safety is expected within the next few years, the best position from a strictly scientific standpoint, is to maintain uncertainty: the ability to be astonished by new discoveries. There is still much to learn from cases such as mass psychogenic illnesses; the biggest mistake to be made is to ignore its association to vaccines,Citation8 even if we do not understand yet how and why they happen. In these cases, both psychological traits and sociocultural environments seem to have important effects that need to be studied with much more detail.

Disclosure of potential conflicts of interest

No potential conflicts of interest were disclosed.

References

  • Simas C, Muñoz N, Arregocés L, Larson HJ. HPV vaccine confidence and cases of mass psychogenic illness following immunization in Carmen de Bolivar, Colombia. Hum Vaccin Immunother. 2019;15(1):163–66. doi:10.1080/21645515.2018.1511667.
  • Martínez M, Estévez A, Quijada H, Walteros D, Tolosa N, Paredes A, Alvarez C, Armenta A, Osorio L, Castillo O. De La Hoz F. Brote de evento de etiología desconocida en el municipio de El Carmen de Bolívar, Bolívar, 2014. Inf Quinc Epidemiol Nac. 2015;20:42–77.
  • Pugsley MK, Authier S, Curtis MJ. Principles of safety pharmacology. Br J Pharmacol. 2008;154:1382–99. doi:10.1038/bjp.2008.280.
  • Idrovo AJ. Three criteria for ecological fallacy. Environ Health Perspect. 2011;119(8):A332. doi:10.1289/ehp.1103768.
  • Mink JW. Conversion disorder and mass psychogenic illness in child neurology. Ann N Y Acad Sci. 2013;1304:40–44. doi:10.1111/nyas.12298.
  • Mamo L, Epstein S. The pharmaceuticalization of sexual risk: vaccine development and the new politics of cancer prevention. Soc Sci Med. 2014;101:155–65. doi:10.1016/j.socscimed.2013.11.028.
  • Rose G. Sick individuals and sick populations. Int J Epidemiol. 1985;14:32–38.
  • Clements CJ. Mass psychogenic illness after vaccination. Drug Saf. 2003;26:599–604. doi:10.2165/00002018-200326090-00001.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.